282 related articles for article (PubMed ID: 31535207)
21. Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis.
Wang Q; You H; Ou X; Zhao X; Sun Y; Wang M; Wang P; Wang Y; Duan W; Wang X; Wu S; Kong Y; Saxena R; Gouw ASH; Jia J
Hepatol Int; 2019 Nov; 13(6):766-776. PubMed ID: 31559605
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
Petta S; Eslam M; Valenti L; Bugianesi E; Barbara M; Cammà C; Porzio M; Rosso C; Fargion S; George J; Craxì A
Liver Int; 2017 Sep; 37(9):1389-1396. PubMed ID: 28235154
[TBL] [Abstract][Full Text] [Related]
23. Clinical profile of non-alcoholic fatty liver disease in nonobese patients.
Lum JHM; Cheah MCC; Leow WQ; Wan WK; Lim TKH; Chow WC; Chang JPE; Goh GBB
J Gastroenterol Hepatol; 2021 Jan; 36(1):257-261. PubMed ID: 32557741
[TBL] [Abstract][Full Text] [Related]
24. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
25. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
26. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
[TBL] [Abstract][Full Text] [Related]
27. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
Qureshi K; Abrams GA
Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
[TBL] [Abstract][Full Text] [Related]
29. Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population.
Rabelo F; Stefano JT; Cavaleiro AM; Lima RVC; de Campos Mazo DF; Carrilho FJ; Correa-Giannella ML; Oliveira CP
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):330-335. PubMed ID: 30087027
[TBL] [Abstract][Full Text] [Related]
30.
Lisboa QC; Nardelli MJ; Pereira PA; Miranda DM; Ribeiro SN; Costa RSN; Versiani CA; Vidigal PVT; Ferrari TCA; Couto CA
World J Hepatol; 2020 Oct; 12(10):792-806. PubMed ID: 33200017
[TBL] [Abstract][Full Text] [Related]
31. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.
Cordeiro A; Pereira SE; Saboya CJ; Ramalho A
Biomed Res Int; 2015; 2015():839253. PubMed ID: 26120587
[TBL] [Abstract][Full Text] [Related]
32. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
33. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
Milić S; Lulić D; Štimac D
World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
Lonardo A; Mantovani A; Lugari S; Targher G
Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
[TBL] [Abstract][Full Text] [Related]
35. Implications of Abdominal Adipose Tissue Distribution on Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: A Chinese General Population Study.
Chiyanika C; Wong VW; Wong GL; Chan HL; Hui SCN; Yeung DKW; Chu WCW
Clin Transl Gastroenterol; 2021 Feb; 12(2):e00300. PubMed ID: 33600104
[TBL] [Abstract][Full Text] [Related]
36. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
[TBL] [Abstract][Full Text] [Related]
37. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
Li G; Rios RS; Wang XX; Yu Y; Zheng KI; Huang OY; Tang LJ; Ma HL; Jin Y; Targher G; Byrne CD; Pan XY; Zheng MH
Br J Nutr; 2022 Jun; 127(11):1613-1620. PubMed ID: 34176541
[TBL] [Abstract][Full Text] [Related]
38. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis.
Kursawe R; Eszlinger M; Narayan D; Liu T; Bazuine M; Cali AM; D'Adamo E; Shaw M; Pierpont B; Shulman GI; Cushman SW; Sherman A; Caprio S
Diabetes; 2010 Sep; 59(9):2288-96. PubMed ID: 20805387
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
[TBL] [Abstract][Full Text] [Related]
40. Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.
Tan EX; Lee JW; Jumat NH; Chan WK; Treeprasertsuk S; Goh GB; Fan JG; Song MJ; Charatcharoenwitthaya P; Duseja A; Imajo K; Nakajima A; Seki Y; Kasama K; Kakizaki S; Lesmana LA; Zheng KI; Zheng MH; Koh CJ; Ho KY; Goh KL; Wong VW; Dan YY
Metabolism; 2022 Jan; 126():154911. PubMed ID: 34648769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]